PDT Partners’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.54M Hold
32,292
– – 0.14% 208
2026
Q2
$2.03M Sell
32,292
-30,734
-49% -$1.96M 0.11% 237
2026
Q1
$4.42M Hold
63,026
– – 0.26% 123
2025
Q4
$5.16M Hold
63,026
– – 0.33% 94
2025
Q3
$3.75M Hold
63,026
– – 0.24% 152
2025
Q2
$2.55M Buy
+63,026
New +$2.84M 0.14% 246

Other funds holding TARS

PDT Partners's TARS Position: Q3 2026 in Review

PDT Partners held its Tarsus Pharmaceuticals (TARS) position steady in Q3 2026 at 32,292 shares worth $2.54M. The position accounts for 0.14% of the portfolio, ranked #208.

PDT Partners first reported a position in TARS in Q2 2025 and has held it in 6 quarters since. The position peaked at $5.16M in Q4 2025. 255 funds tracked by Wall St. Rank hold TARS as of Q3 2026.

  • PDT Partners held 32,292 shares of Tarsus Pharmaceuticals worth $2.54M as of Q3 2026.
  • PDT Partners left its Tarsus Pharmaceuticals share count unchanged in Q3 2026.
  • Tarsus Pharmaceuticals made up 0.14% of PDT Partners's portfolio in Q3 2026, its #208 holding.
  • PDT Partners first reported a position in Tarsus Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
  • PDT Partners's Tarsus Pharmaceuticals position peaked at $5.16M in Q4 2025.
  • 255 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.

Based on PDT Partners's 13F filing for Q3 2026, filed 16 Nov 2026.